Vogenx, Inc.

Pharmaceutical company · Raleigh, North Carolina, United States · Nasdaq: VOGX

Vogenx, Inc. is a pharmaceutical company headquartered in Raleigh, North Carolina, United States. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker VOGX. It has reported private securities offerings to the US SEC, most recently $750,000 sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Vogenx at a glance

Typepharmaceutical company
HeadquartersRaleigh, North Carolina, United States
Earliest incorporation on record2021
Stock listingNasdaq: VOGX
SEC industryPharmaceutical Preparations
SEC CIK1903784
LEI5299004KM33YCDWS6I69

What does Vogenx do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $750,000 sold (2026).

Frequently asked questions about Vogenx

Where is Vogenx headquartered?

Vogenx, Inc. is headquartered in Raleigh, North Carolina, United States.

What does Vogenx do?

Vogenx, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Vogenx a public company?

Yes. Vogenx, Inc. trades on Nasdaq under the ticker VOGX.

When was Vogenx founded?

The earliest incorporation on record for Vogenx, Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences